Company Profile
Kamada manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies. Its portfolio also includes CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants, VARIZIG for post exposure prophylaxis of varicella, WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization, HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis, GLASSIA for intravenous AATD, KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns, and Echis coloratus and Vipera palaestinae Antiserum to treat snake bite. It also distributes biopharmaceutical products in Israel, including BRAMITOB to manage chronic pulmonary infection.
Its portfolio also includes FOSTER to treat asthma, TRIMBOW for chronic obstructive pulmonary disease, PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity, AEROBIKA, an OPEP device, RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria, SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis, IVIG for various immunodeficiency-related conditions, VARITECT for chicken pox and zoster herpes, ZUTECTRA and HEPATECT CP for prevention of hepatitis B, MEGALOTECT CP for CMV virus, RUCONEST for angioedema attack, HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events, ALBUMIN and ALBUMIN for blood plasma, Factor VIII for hemophilia type A, and Factor IX for hemophilia type B. Additionally, it distributes COAGADEX to treat hereditary factor X deficiency.
Its portfolio also includes IXIARO for Japanese encephalitis, VIVOTIF for salmonella typhi, PROCYSBI for nephropathic cystinosis, LAMZEDE for alpha-mannosidosis, RYPLAZIM for hypoplasminogenemia, ELIGARD for prostate cancer, and BEVACIZUMAB KAMADA for various cancers. Incorporated in 1990, the company is headquartered in Rehovot, Israel.